Sign in to our online system or register for a new account to submit a letter of intent.
*The deadline for submitting applications to the Rapid Response: Canada 2019 (Parkinson’s & Related Diseases) program has now passed*
Neurodegenerative diseases of aging are among the least understood and most undertreated diseases today. If ignored, the social and economic costs of managing these diseases will continue to rise. Meeting these challenges requires pioneering approaches to accelerating treatments.
The Rapid Response: Canada program is seed funding. Preliminary or supporting data is not required.
Accepting applications on diet, physical activity, sleep and nutritional supplements, if these applications meet our other scope criteria.
Encourage applications that bring in expertise, technologies or approaches in the following areas to advance the development of therapeutics and tools for neurodegenerative diseases of aging: artificial intelligence, big data, machine learning, data science, computer science, medicinal chemistry, biostatistics and engineering. Read the RFA here.
This option has been removed from the program details, however if this kind of funding is desired please contact the Institute: If the funded project has the potential for significant commercial success, in the grant agreement, the Institute may request, upon significant commercial success, repayment of grant funds to be used for further research funding.
The Institute has updated which tools are in scope. Please read our What We Fund webpage before applying to ensure your project is in scope.
Goal: To provide seed funding for novel, high-risk, high-reward, translational research that will accelerate the development of therapeutics for neurodegenerative diseases of aging.
Funding: A maximum of $200,000 over up to 18 months per project.
Applicant Eligibility: Eligible Principal Applicants must be working in Canada at least 30% of the time at or above the level of Postdoctoral researcher, and be affiliated with a Canada Revenue Agency-qualified donee institution located in Canada. Co-Applicants/Collaborators must be at the post-doctoral level or above and can be working outside Canada.
If the Principal Applicant is not appointed at the institution from which they are applying, they need to apply with a research supervisor (an “Administrative Supervisor”) who is at or above the level of Assistant Professor or equivalent, with an appointment at the institution from which they are applying.
Applicants may appear in any role on any number of projects.
Project Eligibility: Projects must meet two conditions to be eligible:
*Preliminary or supporting data is not required for this program
Please refer to What We Fund for Institute definitions of neurodegenerative diseases of aging, translational research, therapeutic, and tool.
The Rapid Response program will have multiple calls per year, alternating between two different disease groups (outlined below). Applicants should apply to the group best suited to their project.
|Parkinson’s & Related Diseases:||Alzheimer’s & Related Diseases:|
|o Parkinson’s disease||o Alzheimer’s disease|
|o Dementia with Lewy bodies||o Frontotemporal dementia|
|o Multiple system atrophy||o Mild cognitive impairment|
|o Progressive supranuclear palsy||o Vascular contributions to the above|
|o Vascular contributions to the above||o Prodromes to the above|
|o Prodromes to the above|
The Institute welcomes additional inquiries about this program, including whether a potential idea is in scope. For questions related to the Parkinson’s & Related Diseases program, please contact Matthew Sacheli. For questions related to the Alzheimer’s & Related Diseases program please contact Rene Prashad.
There are two stages of the application process:
An application requires the submission of a Letter of Intent which will be reviewed by our scientific review committee. Applicants with high potential projects will then be invited to submit a Proposal. Instructions for submitting the Proposal will be sent to those invited.
Please note that we provide our reviewers an opportunity to ask questions or request additional information about the LOIs and Proposals before the adjudication if they feel it would be helpful. Between August 31 and September 11 you may receive an email from the Institute listing questions asked by reviewers. We typically ask that applicants provide a response to these questions within two business days. Note that responses to these questions are optional, however, responses may have an impact on the quality of discussion on your application.
|Parkinson’s & Related Diseases:|
|Program opens:||May 4, 2018|
|LOI deadline:||August 1, 2018 at 2:00pm EDT|
|Proposal deadline:||November 12, 2018 at 2:00pm EST|
|Anticipated award notification:||January 24, 2019|
|Alzheimer’s & Related Diseases:|
|Program opens:||September 14, 2018|
|LOI deadline:||December 3, 2018 at 2:00pm EST|
|Proposal deadline:||March 28, 2019 at 2:00pm EDT|
|Anticipated award notification:||May 22, 2019|
The Institute will hold a Program Information Webinar for each disease focus, to provide further details on the program and answer any questions. However, if you have questions specific to your project (e.g., project scope), we encourage you to contact us.
Parkinson’s & Related Diseases: June 14, 2018 at 1:00pm EDT
This webinar has passed
Alzheimer’s & Related Diseases: October 12, 2018 at 1:00pm EST
Funding (up to $1.5m) to grantees outside the regular granting mechanism in order to avoid delays in supporting exciting, potentially high-reward work based on previous success for grants awarded by the Weston Brain Institute.
If you’re a current or past Institute grantee, and would like to apply for follow-on funding, please visit the Weston Brain Institute Follow-on Funding page for more details on how to apply.